{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:45:06Z","timestamp":1792856706197,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40122-023-00481-6","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T07:02:52Z","timestamp":1677222172000},"page":"399-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["New Synthetic Opioids: Clinical Considerations and Dangers"],"prefix":"10.1007","volume":"12","author":[{"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martinez Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Vining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Vasterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Fair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair Jose Lopez","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"218","key":"481_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108350","volume":"1","author":"C Florence","year":"2021","unstructured":"Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend. 2021;1(218): 108350.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"481_CR2","first-page":"97","volume":"25","author":"L Manchikanti","year":"2022","unstructured":"Manchikanti L, Singh VM, Staats PS, Trescot AM, Prunskis J, Knezevic NN, et\u00a0al. Fourth wave of opioid (Illicit Drug) overdose deaths and diminishing access to prescription opioids and interventional techniques: cause and effect. Pain Physician. 2022;25(2):97\u2013124.","journal-title":"Pain Physician"},{"issue":"1","key":"481_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","volume":"26","author":"ND Volkow","year":"2021","unstructured":"Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218\u201333.","journal-title":"Mol Psychiatry"},{"issue":"Pt A","key":"481_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2018;134(Pt A):121\u201332.","journal-title":"Neuropharmacology"},{"issue":"1","key":"481_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et\u00a0al. Opioid use disorder. Nat Rev Dis Primer. 2020;6(1):3.","journal-title":"Nat Rev Dis Primer"},{"key":"481_CR6","unstructured":"Abuse NI on D. Overdose Death Rates [Internet]. National Institute on Drug Abuse. 2022. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed 28 Oct 2022."},{"issue":"1","key":"481_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40122-021-00243-2","volume":"10","author":"L Manchikanti","year":"2021","unstructured":"Manchikanti L, Vanaparthy R, Atluri S, Sachdeva H, Kaye AD, Hirsch JA. COVID-19 and the opioid epidemic: two public health emergencies that intersect with chronic pain. Pain Ther. 2021;10(1):269\u201386.","journal-title":"Pain Ther"},{"issue":"4","key":"481_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry"},{"key":"481_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103051","volume":"90","author":"A Kline","year":"2021","unstructured":"Kline A, Mattern D, Cooperman N, Williams JM, Dooley-Budsock P, Foglia R, et\u00a0al. Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors. Int J Drug Policy. 2021;90: 103051.","journal-title":"Int J Drug Policy"},{"key":"481_CR10","unstructured":"National Drug Threat Assessment [Internet]. Report No.: DEA-DCT-DIR-008\u201321. 2021. https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf"},{"issue":"1","key":"481_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","volume":"9","author":"Y Han","year":"2019","unstructured":"Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9(1):282.","journal-title":"Transl Psychiatry"},{"key":"481_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108019","volume":"233","author":"P Skolnick","year":"2022","unstructured":"Skolnick P. Treatment of overdose in the synthetic opioid era. Pharmacol Ther. 2022;233: 108019.","journal-title":"Pharmacol Ther"},{"key":"481_CR13","unstructured":"HAN Archive - 00438 | Health Alert Network (HAN) [Internet]. 2021. https:\/\/emergency.cdc.gov\/han\/2020\/han00438.asp. Accessed 28 Oct 2022."},{"issue":"8","key":"481_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jlcr.3513","volume":"60","author":"JE Blecha","year":"2017","unstructured":"Blecha JE, Henderson BD, Hockley BG, VanBrocklin HF, Zubieta JK, DaSilva AF, et\u00a0al. An updated synthesis of [11C]carfentanil for positron emission tomography (PET) imaging of the \u03bc-opioid receptor. J Label Compd Radiopharm. 2017;60(8):375\u201380.","journal-title":"J Label Compd Radiopharm"},{"key":"481_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110715","volume":"320","author":"JB Zawilska","year":"2021","unstructured":"Zawilska JB, Kuczy\u0144ska K, Kosmal W, Markiewicz K, Adamowicz P. Carfentanil: from an animal anesthetic to a deadly illicit drug. Forensic Sci Int. 2021;320: 110715.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"481_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/add.15260","volume":"116","author":"H Jalal","year":"2021","unstructured":"Jalal H, Burke DS. Carfentanil and the rise and fall of overdose deaths in the United States. Addiction. 2021;116(6):1593\u20139.","journal-title":"Addiction"},{"key":"481_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108599","volume":"221","author":"SM Flynn","year":"2021","unstructured":"Flynn SM, France CP. Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone. Drug Alcohol Depend. 2021;221: 108599.","journal-title":"Drug Alcohol Depend"},{"issue":"22","key":"481_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/ajhp\/zxz208","volume":"76","author":"R Bardsley","year":"2019","unstructured":"Bardsley R. Higher naloxone dosing may be required for opioid overdose. Am J Health Syst Pharm. 2019;76(22):1835\u20137.","journal-title":"Am J Health Syst Pharm"},{"key":"481_CR19","unstructured":"Critical Review Report: Protonitazene [Internet]. Geneva: World Health Organization (Expert Committee on Drug Dependence); 2022; pp. 1\u201316. https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/45th-ecdd\/protonitazene_draft.pdf?sfvrsn=dfb007b3_1"},{"key":"481_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkac062","author":"JL Schumann","year":"2022","unstructured":"Schumann JL, Syrjanen R, Alford K, Mashetty S, Castle JW, Rotella J, et\u00a0al. Intoxications in an Australian Emergency Department Involving \u201cNitazene\u201d benzylbenzimidazole synthetic opioids (etodesnitazene, butonitazene and protonitazene). J Anal Toxicol. 2022. https:\/\/doi.org\/10.1093\/jat\/bkac062.","journal-title":"J Anal Toxicol"},{"key":"481_CR21","unstructured":"Protonitazene [Internet]. Overdose Prevention Strategies. https:\/\/www.overdosepreventionstrategies.org\/glossary\/protonitazene\/. Accessed 22 Oct 2022."},{"key":"481_CR22","unstructured":"Protonitazene: Stronger than Fentanyl | Healthy Life Recovery [Internet]. 2022 https:\/\/healthyliferecovery.com\/protonitazene-new-synthetic-opioid\/. Accessed 22 Oct 2022."},{"key":"481_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109263","volume":"221","author":"MA De Luca","year":"2022","unstructured":"De Luca MA, Tocco G, Mostallino R, Laus A, Caria F, Musa A, et\u00a0al. Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists. Neuropharmacology. 2022;221: 109263.","journal-title":"Neuropharmacology"},{"key":"481_CR24","unstructured":"New, Dangerous Synthetic Opioid in D.C., Emerging in Tri-State Area [Internet]. https:\/\/www.dea.gov\/stories\/2022\/2022-06\/2022-06-01\/new-dangerous-synthetic-opioid-dc-emerging-tri-state-area. Accessec 23 Oct 2022."},{"issue":"5","key":"481_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/ADM.0000000000000775","volume":"15","author":"CL Shover","year":"2021","unstructured":"Shover CL, Falasinnu TO, Freedman RB, Humphreys K. Emerging characteristics of isotonitazene-involved overdose deaths: a case-control study. J Addict Med. 2021;15(5):429\u201331.","journal-title":"J Addict Med"},{"issue":"3","key":"481_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jamainternmed.2021.8114","volume":"182","author":"NP Morris","year":"2022","unstructured":"Morris NP. Opioid use disorder treatment in the age of fentanyl. JAMA Intern Med. 2022;182(3):249\u201350.","journal-title":"JAMA Intern Med"},{"key":"481_CR27","unstructured":"Buprenorphine Treatment of Fentanyl-Related Opioid Use Disorder | Psychiatrist.com [Internet]. 2022. https:\/\/www.psychiatrist.com\/pcc\/addiction\/substance-use-disorders\/buprenorphine-treatment-fentanyl-related-opioid-use-disorder\/. Accessed 0 Oct 2022."},{"key":"481_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","volume":"106","author":"SD Comer","year":"2019","unstructured":"Comer SD, Cahill CM. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019;106:49\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"481_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108832","volume":"141","author":"M Buresh","year":"2022","unstructured":"Buresh M, Nahvi S, Steiger S, Weinstein ZM. Adapting methadone inductions to the fentanyl era. J Subst Abuse Treat. 2022;141: 108832.","journal-title":"J Subst Abuse Treat"},{"key":"481_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001013","author":"NB Varshneya","year":"2022","unstructured":"Varshneya NB, Thakrar AP, Lambert E, Huhn AS. Opioid use disorder treatment in the fentanyl era. J Addict Med. 2022. https:\/\/doi.org\/10.1097\/ADM.0000000000001013.","journal-title":"J Addict Med"},{"issue":"4","key":"481_CR31","first-page":"E697","volume":"25","author":"L Manchikanti","year":"2022","unstructured":"Manchikanti L, Hirsch JA. Comment on \u201ctrends in and characteristics of buprenorphine misuse among adults in the U.S.\u201d Pain Physician. 2022;25(4):E697.","journal-title":"Pain Physician"},{"issue":"2","key":"481_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/10826084.2018.1517175","volume":"54","author":"LE Dayer","year":"2019","unstructured":"Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: three decades of change. Subst Use Misuse. 2019;54(2):331\u20139.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"481_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/jat\/bkx042","volume":"41","author":"KG Shanks","year":"2017","unstructured":"Shanks KG, Behonick GS. Detection of Carfentanil by LC\u2013MS-MS and Reports of Associated Fatalities in the USA. J Anal Toxicol. 2017;41(6):466\u201372.","journal-title":"J Anal Toxicol"},{"key":"481_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000787","author":"DM Papsun","year":"2022","unstructured":"Papsun DM, Krotulski AJ, Logan BK. Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances. Am J Forensic Med Pathol. 2022. https:\/\/doi.org\/10.1097\/PAF.0000000000000787.","journal-title":"Am J Forensic Med Pathol"},{"key":"481_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110686","author":"F Mueller","year":"2021","unstructured":"Mueller F, Bogdal C, Pfeiffer B, Andrello L, Ceschi A, Thomas A, et\u00a0al. Isotonitazene: fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Elsevier enhanced reader. Forensic Sci Int. 2021. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110686.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"481_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jat\/bkx037","volume":"41","author":"DM Swanson","year":"2017","unstructured":"Swanson DM, Hair LS, Strauch Rivers SR, Smyth BC, Brogan SC, Ventoso AD, et\u00a0al. Fatalities involving carfentanil and furanyl fentanyl: two case reports. J Anal Toxicol. 2017;41(6):498\u2013502.","journal-title":"J Anal Toxicol"},{"key":"481_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcac039","author":"KSC De Baerdemaeker","year":"2022","unstructured":"De Baerdemaeker KSC, Dines AM, Hudson S, Sund LJ, Waters ML, Hunter LJ, et\u00a0al. Isotonitazene, a novel psychoactive substance opioid, detected in two cases following a local surge in opioid overdoses. QJM Int J Med. 2022. https:\/\/doi.org\/10.1093\/qjmed\/hcac039.","journal-title":"QJM Int J Med"},{"issue":"320","key":"481_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110686","volume":"1","author":"F Mueller","year":"2021","unstructured":"Mueller F, Bogdal C, Pfeiffer B, Andrello L, Ceschi A, Thomas A, et\u00a0al. Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Forensic Sci Int. 2021;1(320): 110686.","journal-title":"Forensic Sci Int"},{"issue":"278","key":"481_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.forsciint.2017.07.006","volume":"1","author":"B Zilg","year":"2017","unstructured":"Zilg B, Thelander G, Giebe B, Druid H. Postmortem blood sampling\u2014comparison of drug concentrations at different sample sites. Forensic Sci Int. 2017;1(278):296\u2013303.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"481_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2105\/AJPH.2018.304814","volume":"109","author":"AMD King","year":"2019","unstructured":"King AMD, Foley D, Arfken C, Aaron CMD, Sung LMD, Hlavaty LMD. Carfentanil-Associated Mortality in Wayne County, Michigan, 2015\u20132017. Am J Public Health. 2019;109(2):300\u20132.","journal-title":"Am J Public Health"},{"issue":"7","key":"481_CR41","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.toxrep.2020.08.019","volume":"22","author":"BJ McCranor","year":"2020","unstructured":"McCranor BJ, Jennings L, Tressler J, Tuet WY, DeLey Cox VE, Racine M, et\u00a0al. Assessment of naloxone as a therapeutic for inhaled carfentanil in the ferret. Toxicol Rep. 2020;22(7):1112\u201320.","journal-title":"Toxicol Rep"},{"key":"481_CR42","unstructured":"DEA Issues Carfentanil Warning To Police And Public [Internet]. 2022. https:\/\/www.dea.gov\/press-releases\/2016\/09\/22\/dea-issues-carfentanil-warning-police-and-public. Accessed 04 Nov 2022."},{"issue":"2","key":"481_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jemermed.2009.09.026","volume":"40","author":"EB Lust","year":"2011","unstructured":"Lust EB, Barthold C, Malesker MA, Wichman TO. Human health hazards of veterinary medications: information for emergency departments. J Emerg Med. 2011;40(2):198\u2013207.","journal-title":"J Emerg Med"},{"issue":"3","key":"481_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bpa.2020.08.007","volume":"34","author":"I Urits","year":"2020","unstructured":"Urits I, Li N, Berardino K, Artounian KA, Bandi P, Jung JW, et\u00a0al. The use of antineuropathic medications for the treatment of chronic pain. Best Pract Res Clin Anaesthesiol. 2020;34(3):493\u2013506.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"481_CR45","first-page":"E211","volume":"25","author":"JN Nagireddi","year":"2022","unstructured":"Nagireddi JN, Vyas AK, Sanapati MR, Soin A, Manchikanti L. The analysis of pain research through the lens of artificial intelligence and machine learning. Pain Physician. 2022;25(2):E211\u201343.","journal-title":"Pain Physician"},{"issue":"2","key":"481_CR46","first-page":"171","volume":"25","author":"A Soin","year":"2022","unstructured":"Soin A, Hirschbeck M, Verdon M, Manchikanti L. A pilot study implementing a machine learning algorithm to use artificial intelligence to diagnose spinal conditions. Pain Physician. 2022;25(2):171\u20138.","journal-title":"Pain Physician"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00481-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-023-00481-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00481-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T12:05:04Z","timestamp":1679573104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-023-00481-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s40122-023-00481-6","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}